Pediatric leukemia 'super drug' could be developed in the coming years
Fourth study published over two-year span that analyzes key leukemia proteinCredit: Northwestern University CHICAGO --- Northwestern Medicine scientists have discovered ...
Tag: Prostate Cancer
CWRU researcher awarded nearly $1 million from the DOD to study prostate cancer drug resistance
Sanjay Gupta, PhD, of Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center will receive $962,000 ...
Columbia professor uses data science to create personalized cancer therapies
Columbia's Andrea Califano has developed a highly-predictive computer platform that can analyze all tumor types and predict which drug or ...
Time to biochemical failure could be used as surrogate endpoint in treatment: LA prostate cancer
An analysis of the NRG Oncology clinical trial NRG-RTOG 9202 showed that the interval of time to biochemical failure (IBF), ...
Prostate cancer scoring method may underestimate mortality risk in black men
Credit: Dana-Farber Cancer Institute Black men diagnosed with prostate cancer classified as low risk may actually have a more-aggressive form ...
Whole-body PET/MRI provides one-stop shop for staging high-risk prostate cancer patients
Credit: The Journal of Nuclear Medicine New research on prostate cancer staging shows that PSMA-targeted PET/MRI performs equally as well ...
Surgery unnecessary for many prostate cancer patients
Otherwise healthy men with advanced prostate cancer may benefit greatly from surgery, but many with this diagnosis have no need ...
Faster, cheaper test can help predict risk of metastasis in prostate cancer patients
The Next-Generation Copy Number Alteration (NG-CNA) assay can analyze small amounts of material to estimate metastatic risk, reports The Journal ...
Prostate cancer: New computer model enables researchers to predict course of disease
Credit: © Niclas Blessing/UKE How does a normal cell turn into a deadly cancer? Seeking an answer to this question, ...
A new therapeutic target for metastatic and resistant prostate cancers
The study suggests an innovative, combined therapeutic approach that would include the administration of a NSD2 inhibitor drug together with ...